139 related articles for article (PubMed ID: 10482797)
1. 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum.
Royland JE; Delfani K; Langston JW; Janson AM; Di Monte DA
Brain Res; 1999 Aug; 839(1):41-8. PubMed ID: 10482797
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
Muramatsu Y; Kurosaki R; Mikami T; Michimata M; Matsubara M; Imai Y; Kato H; Itoyama Y; Araki T
Metab Brain Dis; 2002 Sep; 17(3):169-82. PubMed ID: 12322787
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
Di Monte DA; Royland JE; Anderson A; Castagnoli K; Castagnoli N; Langston JW
J Neurochem; 1997 Oct; 69(4):1771-3. PubMed ID: 9326308
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
6. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
Yokoyama H; Takagi S; Watanabe Y; Kato H; Araki T
J Neural Transm (Vienna); 2008 Jun; 115(6):831-42. PubMed ID: 18235988
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
Castagnoli K; Palmer S; Castagnoli N
Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
Thomas B; Saravanan KS; Mohanakumar KP
Neurochem Int; 2008 May; 52(6):990-1001. PubMed ID: 18164516
[TBL] [Abstract][Full Text] [Related]
9. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
Yokoyama H; Yano R; Aoki E; Kato H; Araki T
Metab Brain Dis; 2008 Sep; 23(3):335-49. PubMed ID: 18648914
[TBL] [Abstract][Full Text] [Related]
11. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
12. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
Herraiz T; Arán VJ; Guillén H
Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
Boireau A; Dubedat P; Bordier F; Imperato A; Moussaoui S
Neuropharmacology; 2000 Apr; 39(6):1016-20. PubMed ID: 10727711
[TBL] [Abstract][Full Text] [Related]
14. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
Cosi C; Marien M
Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
[TBL] [Abstract][Full Text] [Related]
15. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
Watanabe Y; Kato H; Araki T
Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.
Schulz JB; Matthews RT; Muqit MM; Browne SE; Beal MF
J Neurochem; 1995 Feb; 64(2):936-9. PubMed ID: 7530297
[TBL] [Abstract][Full Text] [Related]
17. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Castagnoli K; Palmer S; Anderson A; Bueters T; Castagnoli N
Chem Res Toxicol; 1997 Apr; 10(4):364-8. PubMed ID: 9114971
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
Samantaray S; Mohanakumar KP
Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
20. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
Perez V; Unzeta M
Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]